Suvretta Capital Management »

Erasca shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $33M 14M 2.36

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Biohaven (BHVN)
Insmed Com Par $.01 (INSM)
Kura Oncology (KURA)
Intra Cellular Therapies (ITCI)
Arcutis Biotherapeutics (ARQT)
Ultragenyx Pharmaceutical (RARE)
Meta Platforms Cl A (META)
Arcellx Common Stock (ACLX)
UnitedHealth (UNH)
Apple (AAPL)
Amazon (AMZN)
89bio (ETNB)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Advanced Micro Devices (AMD)

View all positions for Suvretta Capital Management

Top funds holding Erasca

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Arch Venture Corp
BlackRock
Vanguard Group
Artal Group
Henderson Group
Silverarc Capital Management
T. Rowe Price Investment Management
Paradigm Biocapital Advisors
Logos Global Management
5AM Venture Management
Partner Fund Management
Balyasny Asset Management

View all funds holding Erasca